Episode 10: Among the topics: Tricuspid regurgitation - Cardiogenic shock

ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.

This episode covers:

• Cardiology This Week: A concise summary of recent studies
• Interventional aspects of cardiogenic shock
• Diagnosis and management of tricuspid regurgitation
• Statistics Made Easy: Type I and Type II errors and their significance

Host: Susanna Price Guests: Rebecca Hahn, Nicolle Kraenkel and Holger Thiele

Want to watch that episode? Go to: https://esc365.escardio.org/event/898

 

Disclaimer

This programme is intended for health care professionals only and is to be used for educational purposes.  The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.  Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. 

Declarations of interests 

Stephan Achenbach, Nicolle Kraenkel, Susanna Price and Holger Thiele have declared to have no potential conflicts of interest to report.  

Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede. 

Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi, Daiichi Sankyo, Terumo, Medtronic, Chiesi. 

Rebecca Hahn has declared to have potential conflicts of interest to report: Chief Scientific Officer for the Echocardiography Core Laboratory at the Cardiovascular Research Foundation for multiple industry-sponsored tricuspid valve trials, for which she receives no direct industry compensation.

Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer- Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.